Small-Molecule Inhibitors and Degraders Targeting KRAS-Driven Cancers
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hyun, Soonsil | - |
dc.contributor.author | Shin, Dongyun | - |
dc.date.accessioned | 2021-12-04T01:40:33Z | - |
dc.date.available | 2021-12-04T01:40:33Z | - |
dc.date.created | 2021-11-14 | - |
dc.date.issued | 2021-11 | - |
dc.identifier.issn | 1661-6596 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/82838 | - |
dc.description.abstract | Drug resistance continues to be a major problem associated with cancer treatment. One of the primary causes of anticancer drug resistance is the frequently mutated RAS gene. In particular, considerable efforts have been made to treat KRAS-induced cancers by directly and indirectly controlling the activity of KRAS. However, the RAS protein is still one of the most prominent targets for drugs in cancer treatment. Recently, novel targeted protein degradation (TPD) strategies, such as proteolysis-targeting chimeras, have been developed to render “undruggable” targets druggable and overcome drug resistance and mutation problems. In this study, we discuss small-molecule inhibitors, TPD-based small-molecule chemicals for targeting RAS pathway proteins, and their potential applications for treating KRAS-mutant cancers. Novel TPD strategies are expected to serve as promising therapeutic methods for treating tumor patients with KRAS mutations. © 2021 by the authors. Licensee MDPI, Basel, Switzerland. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.relation.isPartOf | International Journal of Molecular Sciences | - |
dc.title | Small-Molecule Inhibitors and Degraders Targeting KRAS-Driven Cancers | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000723342200001 | - |
dc.identifier.doi | 10.3390/ijms222212142 | - |
dc.identifier.bibliographicCitation | International Journal of Molecular Sciences, v.22, no.22 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85118668706 | - |
dc.citation.title | International Journal of Molecular Sciences | - |
dc.citation.volume | 22 | - |
dc.citation.number | 22 | - |
dc.contributor.affiliatedAuthor | Shin, Dongyun | - |
dc.type.docType | Review | - |
dc.subject.keywordAuthor | Drug resistance | - |
dc.subject.keywordAuthor | KRAS inhibitors | - |
dc.subject.keywordAuthor | KRAS mutant | - |
dc.subject.keywordAuthor | PROTAC | - |
dc.subject.keywordAuthor | RAS | - |
dc.subject.keywordAuthor | Targeted protein degradation (TPD) | - |
dc.subject.keywordPlus | SHP2 | - |
dc.subject.keywordPlus | MUTATIONS | - |
dc.subject.keywordPlus | POTENT | - |
dc.subject.keywordPlus | DISCOVERY | - |
dc.subject.keywordPlus | AFFINITY | - |
dc.subject.keywordPlus | KINASE | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.